Literature DB >> 8005161

Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.

I Khalkhali1, I Mena, L Diggles.   

Abstract

Imaging techniques currently used for the diagnosis of breast cancer are reviewed and compared. Besides mammography, magnetic resonance imaging, positron emission tomography, and thallium-201 scintimammography, a new role of technetium-99m sestamibi scintimammography is discussed. It is concluded that while mammography remains the procedure of choice in screening asymptomatic women for breast cancer, other imaging methods play an important role in detecting malignancies in symptomatic patients. 99mTc-sestamibi scintimammography has high sensitivity and improves the specificity of conventional mammography for the detection of breast cancer; with this technique, prone imaging is preferable to supine imaging. 99mTc-sestamibi scintimammography thus deserves further study as a screening technique.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8005161     DOI： 10.1007/BF00947973

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  40 in total

1.  Recurrence of colorectal tumors: PET evaluation.

Authors:  L G Strauss; J H Clorius; P Schlag; B Lehner; B Kimmig; R Engenhart; M Marin-Grez; F Helus; F Oberdorfer; P Schmidlin
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

2.  Principles in mass screening for breast cancer.

Authors:  P Strax; G Martin
Journal:  Cancer Detect Prev       Date:  1987

3.  Costs of screening for breast cancer.

Authors:  M Moskowitz
Journal:  Radiol Clin North Am       Date:  1987-09       Impact factor: 2.303

4.  Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.

Authors:  P A Carvalho; M L Chiu; J F Kronauge; M Kawamura; A G Jones; B L Holman; D Piwnica-Worms
Journal:  J Nucl Med       Date:  1992-08       Impact factor: 10.057

5.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

Authors:  R L Wahl; R L Cody; G D Hutchins; E E Mudgett
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

6.  Multicentricity of non-palpable breast cancer.

Authors:  G F Schwartz; A S Patchesfsky; S A Feig; G S Shaber; A B Schwartz
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

7.  Thallium scintigraphy in the evaluation of mass abnormalities of the breast.

Authors:  A D Waxman; L Ramanna; L D Memsic; C E Foster; A W Silberman; S H Gleischman; R J Brenner; M B Brachman; C J Kuhar; J Yadegar
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057

8.  Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.

Authors:  B Caner; M Kitapçi; T Aras; G Erbengi; O Uğur; C Bekdik
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

9.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

10.  Mammographic features of 300 consecutive nonpalpable breast cancers.

Authors:  E A Sickles
Journal:  AJR Am J Roentgenol       Date:  1986-04       Impact factor: 3.959
View more
  23 in total

1.  Toward 7T breast MRI clinical study: safety assessment using simulation of heterogeneous breast models in RF exposure.

Authors:  Xin Li; Joseph V Rispoli
Journal:  Magn Reson Med       Date:  2018-09-14       Impact factor: 4.668

Review 2.  The role of nuclear medicine in clinical investigation.

Authors:  E M Prvulovich; J B Bomanji
Journal:  BMJ       Date:  1998-04-11

3.  Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography.

Authors:  W W Lam; W T Yang; Y L Chan; I E Stewart; C Metreweli; W King
Journal:  Eur J Nucl Med       Date:  1996-05

Review 4.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.

Authors:  Carrie B Hruska; Michael K O'Connor
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

5.  [Molecular breast imaging. An update].

Authors:  K Pinker; T H Helbich; H Magometschnigg; B Fueger; P Baltzer
Journal:  Radiologe       Date:  2014-03       Impact factor: 0.635

6.  Exaggerated role of prone technique in breast cancer imaging with technetium-99m methoxyisobutylisonitrile.

Authors:  C Aktolun
Journal:  Eur J Nucl Med       Date:  1994-11

7.  Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.

Authors:  Jason M Williams; Sudheer D Rani; Xia Li; Lori R Arlinghaus; Tzu-Cheng Lee; Lawrence R MacDonald; Savannah C Partridge; Hakmook Kang; Jennifer G Whisenant; Richard G Abramson; Hannah M Linden; Paul E Kinahan; Thomas E Yankeelov
Journal:  Med Phys       Date:  2015-07       Impact factor: 4.071

8.  Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.

Authors:  Richard G Abramson; Katrina F Lambert; Laurie B Jones-Jackson; Lori R Arlinghaus; Jason Williams; Vandana G Abramson; A Bapsi Chakravarthy; Thomas E Yankeelov
Journal:  Acad Radiol       Date:  2015-04-10       Impact factor: 3.173

9.  Visualisation of a paraganglioma by technetium-99m-sestamibi scintigraphy.

Authors:  M Piga; G P Farina; G L Loi; A Serra; M A Calia; L Lai; G Zucca; S Mariotti
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 10.  Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.

Authors:  Giuseppe Madeddu; Angela Spanu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-15       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.